Advancements in Aptamer‐Driven DNA Nanostructures for Precision Drug Delivery
Advanced Science · 2024-07 · 11 (26)
DOI: 10.1002/advs.202401617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 07.05.2024. Verfasst von Moein Safarkhani und 7 weiteren Autor:innen. Beteiligte Einrichtung: NanoBio High-Tech Materials Research Center, Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Incheon, 22212, Repu…. Hauptthemen laut MEDLINE: Nanostructures, Aptamers, Nucleotide, Drug Delivery Systems, DNA. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
DNA nanostructures exhibit versatile geometries and possess sophisticated capabilities not found in other nanomaterials. They serve as customizable nanoplatforms for orchestrating the spatial arrangement of molecular components, such as biomolecules, antibodies, or synthetic nanomaterials. This is achieved by incorporating oligonucleotides into the design of the nanostructure. In the realm of drug delivery to cancer cells, there is a growing interest in active targeting assays to enhance efficacy and selectivity. The active targeting approach involves a “key‐lock” mechanism where the carrier, through its ligand, recognizes specific receptors on tumor cells, facilitating the release of drugs. Various DNA nanostructures, including DNA origami, Tetrahedral, nanoflower, cruciform, nanostar, nanocentipede, and nanococklebur, can traverse the lipid layer of the cell membrane, allowing cargo delivery to the nucleus. Aptamers, easily formed in vitro, are recognized for their targeted delivery capabilities due to their high selectivity for specific targets and low immunogenicity. This review provides a comprehensive overview of recent advancements in the formation and modification of aptamer‐modified DNA nanostructures within drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NanoBio High-Tech Materials Research Center, Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Incheon, 22212, Republic of Korea.
- School of Chemistry, Damghan University, Damghan, 36716-45667, Iran.
- Department of Chemical Engineering, McMaster University, Hamilton, L8S 4L8, Canada.
- Department of Pharmaceutical Chemistry, Medical University of Gdańsk, J. Hallera 107, Gdańsk, 80-416, Poland.
- The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, 324000 Quzhou, Zhejiang, China.
- Centre of Research Impact and Outreach, Chitkara University, Rajpura, Punjab, 140417, India.
ORCID-Profile: Majid Ebrahimi Warkiani
Förderung
- National Research Foundation of Korea
Zitieren
APA
Safarkhani, M., Ahmadi, S., Ipakchi, H., Saeb, M. R., Makvandi, P., Ebrahimi Warkiani, M., Rabiee, N., & Huh, Y. (2024). Advancements in Aptamer‐Driven DNA Nanostructures for Precision Drug Delivery. Advanced Science, 11(26). https://doi.org/10.1002/advs.202401617
Vancouver
Safarkhani M, Ahmadi S, Ipakchi H, Saeb MR, Makvandi P, Ebrahimi Warkiani M, et al. Advancements in Aptamer‐Driven DNA Nanostructures for Precision Drug Delivery. Advanced Science. 2024;11(26). doi:10.1002/advs.202401617
BibTeX
@article{Safarkhani2024,
author = {Safarkhani, Moein and Ahmadi, Sepideh and Ipakchi, Hossein and Saeb, Mohammad Reza and Makvandi, Pooyan and Ebrahimi Warkiani, Majid and Rabiee, Navid and Huh, YunSuk},
title = {Advancements in Aptamer‐Driven DNA Nanostructures for Precision Drug Delivery},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {26},
doi = {10.1002/advs.202401617}
}
EUVIMED